Sort
326,823 grants matching “clinical trial”
Cancer and Leukemia Group B
$1,578,848University Of Chicago · U10 · FY2004 · CA
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation
$1,578,717Christine Marie Durand · Johns Hopkins University · U01 · FY2017 · AI
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)
$1,578,677Jeanette Coffin · Midwest Research Institute · N01 · FY2023 · AI
Growth Factor Imaging and Photoimmunotherapy
$1,578,593Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against
$1,578,528Lloyd M Yu · Planet Biotechnology, Inc. · R01 · FY2011 · AI
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain
$1,578,495George Kenneth Lewis · Zetroz Systems, Llc · R44 · FY2024 · MD
MULTICENTER VITAMIN E TRIAL-PERSONS WITH DOWN SYNDROME
$1,578,452Institute For Basic Res In Dev Disabil · R01 · FY2002 · AG
SmartInsulin ADME and IND-enabling Preclinical Studies
$1,578,278Todd C Zion · Smartcells, Inc. · R44 · FY2009 · DK
Alopecia Areata Center for Research Translation (AACORT)
$1,578,101Angela M Christiano · Columbia University Health Sciences · P50 · FY2018 · AR
Magnetic Resonance Imaging-Guided Cancer Interventions
$1,578,070Kim Butts Pauly · Stanford University · P01 · FY2013 · CA
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
$1,578,014Andrea Lynne Gropman · Children'S Research Institute · U54 · FY2022 · HD
Makerere Univ.-Johns Hopkins Univ. HIV Clinical Trials Unit-Kampala, Uganda
$1,577,922Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2012 · AI
Delaware Christiana Care NCORP
$1,577,902Gregory A Masters · Christiana Care Health Services, Inc. · UG1 · FY2019 · CA
Clinical development of mechanism-based lymphoma therapies
$1,577,900Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,577,900Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Physicians Health Study II: Prevention Trial of Vitamins
$1,577,840Brigham And Women'S Hospital · R01 · FY2004 · CA
Precision Medicine in the Diagnosis of Genetic Disorders in Neonates
$1,577,491Jonathan M. Davis · Tufts Medical Center · U01 · FY2021 · TR
HSC DIFFERENTIATION
$1,577,448Children'S Hospital Los Angeles · P50 · FY2004 · HL
Protein Structure
$1,577,338Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Immunologic Basis of Cow's Milk-Induced Hypersensitivities
$1,577,203Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2012 · AI
Evaluation of Predictive Signatures of Prostate Cancer
$1,577,163Dan Mercola · University Of California-Irvine · U01 · FY2008 · CA
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
$1,577,126Jonathan L. Haines · Case Western Reserve University · R01 · FY2023 · AG
LIVE, ATTENUATED, RECOMBINANT VACCINE - WEST NILE VIRUS
$1,577,110Acambis, Inc. · R01 · FY2002 · AI
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
$1,577,015David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2023 · HL
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
$1,577,000Frank Louis Meyskens · · N01 · FY2007 · CA